References
- Abbott. Abbott RealTime HIV-1. Abbott. 2012.
- Abecasis AB, Wensing AMJ, Paraskevis D, Vercauteren J, Kristof T, Vijver DAV, Albert J, Asjo B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Gascun C, Griskevicius A, Grossman Z, Hamouda O, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Kucherer C, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stockl E, Schmit JC, Sonnerborg A, Stanekova D, Stanojevic M, Struck D, Boucher CAB, Vandamme AM. HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology. 2013. 10: 7. https://doi.org/10.1186/1742-4690-10-7
- AIDSinfor. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. ADISinfor. 2014.
- Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR. Under-evaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J Acquir Immune Defic Syndr. 2002. 31: 488-494. https://doi.org/10.1097/00126334-200212150-00006
- Amendola A, Marsella P, Bloisi M, Forbici F, Angeletti C, Capobianchi MR. Ability of two commercially available assays (Abbott RealTime HIV-1 and Cobas AmpliPrep/Cobas Taq-Man HIV-1 version 2.0) to quantify low HIV-1 RNA levels (<1,000 copies/milliliter): Comparison with clinical samples and NIBSC working reagent for nucleic aci. J Clin Microbiol. 2014. 52: 2019-2026. https://doi.org/10.1128/JCM.00288-14
- Buonaguro L, Tornesello ML, Buonaguro FM. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol. 2007. 81: 10209-10219. https://doi.org/10.1128/JVI.00872-07
- Clarke JR, Galpin S, Braganza R, Ashraf A, Russell R, Churchill DR, Weber JN, McClure MO. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients. J Med Virol 2000. 62: 445-449. https://doi.org/10.1002/1096-9071(200012)62:4<445::AID-JMV8>3.0.CO;2-N
- de Mendoza C, Alcami J, Folgueira D, Soriano V. Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma. J Clin Microbiol. 2002. 40: 1518-1521. https://doi.org/10.1128/JCM.40.4.1518-1521.2002
- Geelen S, Lange J, Borleffs J, Wolfs T, Weersink A, Schuurman R. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission. AIDS. 2003. 17: 781-782. https://doi.org/10.1097/00002030-200303280-00027
- Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006. 20: W13-W23. https://doi.org/10.1097/01.aids.0000247564.73009.bc
- Holguin A, de Mendoza C, Soriano V. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with Non-B HIV-1 subtypes. Eur J Clin Microbiol Infect Dis. 1999. 18: 256-259. https://doi.org/10.1007/s100960050273
- Jagodzinski LL, Wiggins DL, McManis JL, Emery S, Overbaugh J, Robb M, Bodrug S, Michael NL. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol. 2000. 38: 1247-1249.
- Jung D, Lee H, Park S. Mycobacterium tuberculosis DNA detection and molecular drug susceptibility test in AFB-stained sputum slides. Biomed Sci Lett. 2016. 22: 24-28. https://doi.org/10.15616/BSL.2016.22.1.24
- Korea CDC. Molecular epidemiology of HIV in Korea. KCDC. 2008. 1: 581-584.
- Lee S, Wood O, Taffs RE, Hu J, Machuca A, Vallejo A, Hewlett I. Development and evaluation of HIV-1 subtype RNA panels for the standardization of HIV-1 NAT assays. J Virol Methods. 2006. 137: 287-291. https://doi.org/10.1016/j.jviromet.2006.07.001
- MacNeil A, Sarr AD, Sankale JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol. 2007. 81: 5325-5330. https://doi.org/10.1128/JVI.02625-06
- Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994. 265: 1587-1590. https://doi.org/10.1126/science.7915856
- Marlink RG, Ricard D, M'Boup S, Kanki PJ, Romet-Lemonne JL, N'Doye I, Diop K, Simpson M, Greco F, Chou MJ. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res Hum Retroviruses. 1988. 4: 137-148. https://doi.org/10.1089/aid.1988.4.137
- Michael NL, Herman SA, Kwok S, Dreyer K, Wang J, Christopherson C, Spadoro JP, Young KKY, Polonis V, McCutchan FE, Carr J, Mascola JR, Jagodzinski LL, Robb ML. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol. 1999. 37: 2557-2563.
- Moss JA. HIV/AIDS Review. Radiol Technol. 2013. 84: 247-267.
- Oh IY, Kim KT, Jun JH, Shin J-H, Sung HJ. Development of real-time PCR assays for detection of Dirofilaria immitis from infected dog blood. Korean J Clin Lab Sci. 2016. 48: 88-93. https://doi.org/10.15324/kjcls.2016.48.2.88
- Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J, WHO-UNAIDS Network for HIV Isolation and Characterization. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002. 29: 184-190. https://doi.org/10.1097/00042560-200202010-00013
- Park M-S, Cho H-W, Kim J-G, Bae N-Y, Oh D-S, Park H-H. Genotype analysis of human papilloma virus infection in accordance with cytological diagnoses. Korean J Clin Lab Sci. 2015. 47: 39-45. https://doi.org/10.15324/kjcls.2015.47.1.39
- Plantier J-C, Leoz M, Dickerson JE, Jonathan E, Oliveira F, Cordonnier F, Lemee V, Damond F, Robertson DL, Simon F. A new human immunodeficiency virus derived from gorillas. Nat Med. 2009. 15: 871-872. https://doi.org/10.1038/nm.2016
- Qiagen. artus HI Virus-1 QS-RGQ performance characterics. Qiagen. 2012.
- Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol. 2002. 83: 1253-1265. https://doi.org/10.1099/0022-1317-83-6-1253
- Roche. COBAS AmpliPrep/COBAS TanMan HIV-1 Test-Ver.2. Roche. 2013.
- Shin HI, Kim IC, Cho TJ. Replication and encapsidation of recombinant turnip yellow mosaic virus RNA. BMB Rep. 2008. 41: 739-744. https://doi.org/10.5483/BMBRep.2008.41.10.739
- Swanson P, de Mendoza C, Joshi Y, Golden A, Hodinka RL, Soriano V, Devare SG, Hackett J. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol. 2005. 43: 3860-3868. https://doi.org/10.1128/JCM.43.8.3860-3868.2005
- Swanson P, Harris BJ, Holzmayer V, Devare SG, Schochetman G, Hackett Jr. J. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay. J Virol Methods. 2000. 89: 97-108. https://doi.org/10.1016/S0166-0934(00)00205-6
- Takebe Y, Kusagawa S, Motomura K. Molecular epidemiology of HIV: Tracking AIDS pandemic. Pediatr Int. 2004. 46: 236-244. https://doi.org/10.1046/j.1442-200x.2004.01869.x
- Taylor BS, Hammer SM. The challenge of HIV-1 subtype diversity. N Engl J Med. 2008. 359: 1965-1966. https://doi.org/10.1056/NEJMc086373
- Triques K, Coste J, Perret JL, Segarra C, Mpoudi E, Reynes J, Delaporte E, Butcher A, Dreyer K, Herman S, Spadoro J, Peeters M. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR Test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol. 1999. 37: 110-116.
- Weiss RA. How does HIV cause AIDS? Science. 1993. 260: 1273-1279. https://doi.org/10.1126/science.8493571